We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App


31 Jul 2024 - 02 Aug 2024
02 Aug 2024 - 04 Aug 2024
20 Aug 2024 - 22 Aug 2024

Medtronic Finalizes Covidien Acquisition for USD 50 Billion

By HospiMedica International staff writers
Posted on 01 Feb 2015
Print article
Medtronic (Minneapolis, MN, USA and Dublin, Ireland) completed its acquisition of Covidien (Dublin, Ireland) in lockstep with the Irish High Court’s sanctioning. The companies, both major medical manufacturers of cardiovascular devices, now exist under the name Medtronic plc, with principal executive offices now headquartered in Ireland, which has a much lower corporate tax rate than the US, allowing Medtronic to lower its tax burden. Its operational headquarters remain in Minneapolis and its chairman and CEO, Omar Ishrak, will oversee the company from Minneapolis.

The acquisition allowed the companies to combine a variety of cardiovascular product lines and services, including implantable cardiac therapies such as pacemakers and defibrillators, valves, catheter-based ablation systems, stents, and vascular and peripheral technologies.

The deal is also an opportunity to expand products and services via Covidien’s reach in emerging markets. Covidien employed about 38,000 in more than 70 countries, with 41 manufacturing facilities in 17 countries; Medtronic’s workforce was about 46,000, with 8,000 in Minneapolis. Medtronic plc now totals about 85,000 employees working in 160 countries.

“Through this combination, Medtronic is expected to generate significant free cash flow, which it will be able to deploy with greater strategic flexibility, particularly in the US,” the companies said in a joint statement. Medtronic also plans to use USD 10 billion over a decade in the US to invest in early-stage companies and fund acquisitions.

Medtronic announced in June 2014 that it planned to buy Covidien for USD 43 billion and that it agreed to a cash-and-stock deal. The final transaction totaled almost USD 50 billion. Covidien and Medtronic shares have ceased trading, being replaced by Medtronic plc shares (MDT).

Related Links:


Gold Member
Solid State Kv/Dose Multi-Sensor
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Compact 14-Day Uninterrupted Holter ECG
1.5T MRI Scanner

Print article


Critical Care

view channel
Image: A visualization of the blood-brain barrier disruption one hour post-treatment as noted by the diffusion of normally impermeant (Photo courtesy of APL Bioengineering)

New Technique Treats Aggressive Brain Tumors by Disrupting Blood-Brain Barrier

Glioblastoma, the most common malignant brain tumor, accounts for more than half of all such cancers. Despite the use of aggressive treatments like surgery, chemotherapy, and radiotherapy, the prognosis... Read more

Surgical Techniques

view channel
Image: ImmersiveAR is an FDA-510(k) cleared augmented reality (AR) software (Photo courtesy of 123RF)

Breakthrough AR Surgical System Brings Precision-Enhanced Visualization into the OR

State-of-the-art mixed reality and artificial intelligence (AI) technologies are revolutionizing the field of surgery. Now, a groundbreaking augmented reality (AR) technology platform enables surgeons... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University)

POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results

On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.